foxo4 dri senolytic peptide human trials inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway FOXO4 DRI UK Senolytic Peptide Research Peptides Lab UK FOXO4 DRI FOXO4 p53 Peptide Peptagon Buy FOXO4 DRI Exceptional 99%+ Purity Third Party COA Included
Pay in 4 interest-free payments of $7.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14




